Within the Pet Medical Administration market taxonomy, product Types are classified into Oral, Injectable, Topical, Transdermal, and Inhalation delivery systems, each comprising distinct sub‑categories that shape overall market volume. Oral products—tablets, chewables, and liquid suspensions—represent the largest share (approximately 50 %) because they align with owner convenience and can be administered without professional assistance. Injectable formulations, including subcutaneous, intramuscular, and intravitreal agents, account for roughly 30 % of market value; their higher unit price and requirement for veterinary handling limit frequency but drive revenue per dose. Topical options—spot‑on, creams, and shampoos—contribute about 12 % and are favored for parasite control and dermatologic conditions where systemic exposure is undesirable. Transdermal patches and gels, emerging as a niche (~5 %), address chronic pain and hormonal therapies by providing sustained release through the skin. Inhalation devices, still nascent (<3 %), are used primarily for respiratory ailments in small animals. The aggregation of these type‑level segments explains the composite market size, with oral dominance offset by higher‑margin injectable sales, thereby informing pricing strategies and supply‑chain prioritization.